DE69616072D1 - Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung - Google Patents

Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung

Info

Publication number
DE69616072D1
DE69616072D1 DE69616072T DE69616072T DE69616072D1 DE 69616072 D1 DE69616072 D1 DE 69616072D1 DE 69616072 T DE69616072 T DE 69616072T DE 69616072 T DE69616072 T DE 69616072T DE 69616072 D1 DE69616072 D1 DE 69616072D1
Authority
DE
Germany
Prior art keywords
enalapril
production
solid formulation
stable solid
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69616072T
Other languages
English (en)
Other versions
DE69616072T2 (de
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24034300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69616072(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE69616072D1 publication Critical patent/DE69616072D1/de
Application granted granted Critical
Publication of DE69616072T2 publication Critical patent/DE69616072T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69616072T 1995-08-04 1996-07-30 Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung Expired - Fee Related DE69616072T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US511297 1995-08-04
US08/511,297 US5573780A (en) 1995-08-04 1995-08-04 Stable solid formulation of enalapril salt and process for preparation thereof
PCT/CA1996/000513 WO1997005881A1 (en) 1995-08-04 1996-07-30 Stable solid formulation of enalapril salt and process for preparation thereof

Publications (2)

Publication Number Publication Date
DE69616072D1 true DE69616072D1 (de) 2001-11-22
DE69616072T2 DE69616072T2 (de) 2009-09-10

Family

ID=24034300

Family Applications (4)

Application Number Title Priority Date Filing Date
DE05076813T Pending DE05076813T1 (de) 1995-08-04 1996-07-30 Stabile feste Formulierung eines Enalaprilsalzes und Verfahren zu dessen Herstellung
DE04078149T Pending DE04078149T1 (de) 1995-08-04 1996-07-30 Stabile feste Zusammensetzung von Enalaprilsalz und dessen Herstellung
DE04076118T Pending DE04076118T1 (de) 1995-08-04 1996-07-30 Stabile Feststoffzusammensetzung aus Enalaprilsalz und deren Herstellung
DE69616072T Expired - Fee Related DE69616072T2 (de) 1995-08-04 1996-07-30 Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DE05076813T Pending DE05076813T1 (de) 1995-08-04 1996-07-30 Stabile feste Formulierung eines Enalaprilsalzes und Verfahren zu dessen Herstellung
DE04078149T Pending DE04078149T1 (de) 1995-08-04 1996-07-30 Stabile feste Zusammensetzung von Enalaprilsalz und dessen Herstellung
DE04076118T Pending DE04076118T1 (de) 1995-08-04 1996-07-30 Stabile Feststoffzusammensetzung aus Enalaprilsalz und deren Herstellung

Country Status (14)

Country Link
US (2) US5573780A (de)
EP (4) EP1442746A1 (de)
JP (1) JP3290994B2 (de)
AT (1) ATE288271T1 (de)
AU (1) AU697696C (de)
BR (1) BR9609964A (de)
CA (1) CA2166001C (de)
DE (4) DE05076813T1 (de)
DK (1) DK0841930T3 (de)
ES (4) ES2264912T1 (de)
IL (1) IL123185A (de)
NZ (1) NZ313576A (de)
RU (1) RU2161970C2 (de)
WO (1) WO1997005881A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
US6296871B1 (en) * 1998-04-12 2001-10-02 Ranbaxy Laboratories Limited Stable solid pharmaceutical compositions containing enalapril maleate
US6153223A (en) * 1998-06-05 2000-11-28 Watson Pharmaceuticals, Inc. Stabilized pharmaceutical compositions
NZ333206A (en) * 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
US6637359B1 (en) * 1998-12-15 2003-10-28 Maritrans Inc. System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
US6555551B1 (en) 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US6764694B1 (en) * 1999-08-31 2004-07-20 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
AU2003235579A1 (en) * 2002-01-15 2003-07-30 Delta Hf. Formulations of quinapril and related ace inhibitors
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
PL1948224T3 (pl) 2005-11-17 2014-10-31 Silverstone Pharma Est Trwały preparat amorficznych soli peryndoprylu, sposób ich wytwarzania, zwłaszcza wytwarzania w skali przemysłowej oraz ich zastosowanie w terapii nadciśnienia
EP2585051B2 (de) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmazeutische orale dosierformen mit lercandipin und enalapril und ihren pharmazeutisch akzeptablen salzen
EP2654729B1 (de) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Orale homogene pharmazeutische zubereitung enthaltend lercanidipine und enalapril oder ihre pharmazeutische salze zusammen mit einer organischen säure
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
SI9111842A (sl) * 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
WO1994001093A1 (en) * 1992-07-09 1994-01-20 Merck & Co., Inc. Controlled porosity osmotic enalapril pump
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
JPH10511103A (ja) 1998-10-27
IL123185A (en) 2001-08-08
DE05076813T1 (de) 2006-11-30
WO1997005881A1 (en) 1997-02-20
AU6608496A (en) 1997-03-05
DE04076118T1 (de) 2005-02-10
ES2245275T1 (es) 2006-01-01
EP1442746A1 (de) 2004-08-04
ES2236741T3 (es) 2005-07-16
RU2161970C2 (ru) 2001-01-20
JP3290994B2 (ja) 2002-06-10
ES2264912T1 (es) 2007-02-01
DE69616072T2 (de) 2009-09-10
ATE288271T1 (de) 2005-02-15
EP1527780A1 (de) 2005-05-04
CA2166001C (en) 2005-12-27
US5690962A (en) 1997-11-25
NZ313576A (en) 1999-05-28
EP1637142A3 (de) 2008-04-02
DE04078149T1 (de) 2005-12-29
EP0841930A1 (de) 1998-05-20
DK0841930T3 (da) 2005-04-25
IL123185A0 (en) 1998-09-24
BR9609964A (pt) 1999-02-02
EP1637142A2 (de) 2006-03-22
EP0841930B1 (de) 2005-02-02
AU697696B2 (en) 1998-10-15
ES2223315T1 (es) 2005-03-01
CA2166001A1 (en) 1996-12-05
US5573780A (en) 1996-11-12
AU697696C (en) 2006-04-06

Similar Documents

Publication Publication Date Title
ATE288271T1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
TR200000832A2 (tr) Sıkıştırılmış kalıp cisimleri için yoğunlaştırılmış patlayıcı taneler.
NZ527585A (en) Tablets quickly disintegrated in oral cavity
ATE342714T1 (de) Verfahren zur herstellung von oralen calcium zusammensetzungen
KR970703133A (ko) 중합체 매트릭스 중의 활성제의 고용체 형태로서의 활성제 제제의 제조 방법 및 그에 의해 얻어진 활성제 제제(Process for Producing Active Agent Preparations in the Form of a Solid Solution of the Active Agent in a Polymer Matrix and Active Agent Preparations Obtained Thereby)
KR910014120A (ko) 피모벤단의 경구용 약제학적 제제
BR9607189A (pt) Formas de dosagem oral contendo um antibiótico de b-lactama
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
CA2263307A1 (en) Aqueous dehydrofluorination method
AU8341691A (en) Stabilized solid chemical compositions
TR199700914A2 (xx) Polivinil alkol kompozisyonlar.
AU3483497A (en) Solid solution of an antifungal agent with enhanced bioavailability
ATE17650T1 (de) Trockenpulverisierte n-acetyl-p-aminophenolzusammensetzungenund verfahren zu deren herstellung.
JPS56155203A (en) Production of carboxyl group-containing polymer material
EP0107086A3 (de) Änderung der Betonerstarrung mit eingekapseltem oberflächenaktiven Mittel
DE3868245D1 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
EA199900193A1 (ru) Грануляты, содержащие водорастворимое соединение и целлюлозу
DE69524226D1 (de) Verfahren zum herstellen von fusidinsäuretabletten
JPS5452718A (en) Preparation of solid pharmaceuticals
AU2001276470A1 (en) Coating tablets
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
JPS56169124A (en) Synthesizing method for ammonia
JPS52141856A (en) Method of revovery of polyvinyl alcohol
GEP20022666B (en) Improved Coated Pesticidal Matrices, a Process for Their Preparation and Compositions Containing Them
TW362019B (en) Stable preparation of sodium 1,4-dimethylisopropylazulene-3-sulfonate and process thereof

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8339 Ceased/non-payment of the annual fee
8363 Opposition against the patent